ABBV-221An intravenously-administered agent capable of modulating the activity of epidermal growth factor receptor (EGFR), with potential antineoplastic activity.Check for active clinical trials using this agentView this agent in the NCI ThesaurusSearch NCI's Drug DictionaryStarts withContainsPlease enter up to 30 characters for your searchBrowse:ABCDEFGHIJKLMNOPQRSTUVWXYZ#
